Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aptinyx Inc (NQ: APTX )

2.860 USD +0.010 (+0.35%)
Official Closing Price Updated: 5:39 PM EDT, Apr 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aptinyx Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
3 Hot Penny Stocks To Watch With Important Biotech Events In April 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Cara Therapeutics (NASDAQ:CARA) shares rose 11.88% to $26.65 during Tuesday's pre-market session. The ... 
Tags Top Gainers Pre/Market Outlook ILMN
From Benzinga
The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GRCL HTGM Earnings
From Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 60.6% to $7.50 in pre-market trading as multiple Form 3 filings late ... 
Tags Market News WEI Small Cap
From Benzinga
Aptinyx Stock Is Trading Higher After Restarting NYX-458 Study In Dementia Associated Cognitive Impairment
Aptinyx Inc(NASDAQ:APTX) hasrestarted patient screeningin aPhase 2 studyevaluating NYX-458 in ... 
Tags Penny Stocks Benzinga General
From Benzinga
Aptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson’s Disease Dementia and Dementia with Lewy Bodies
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that it has... 
From Business Wire News Releases
Aptinyx Inc. (APTX) Q4 2020 Earnings Call Transcript
APTX earnings call for the period ending December 31, 2020. 
Tags Market News APTX
From Motley Fool
Aptinyx: Q4 Earnings Insights
Shares of Aptinyx (NASDAQ:APTX) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per ... 
Tags BZI/Recaps APTX Market News
From Benzinga
Aptinyx Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today reported financial results for... 
From Business Wire News Releases
The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags LH BLFS KLDO
From Benzinga
Earnings Scheduled For March 24, 2021
Companies Reporting Before The Bell • Enerpac Tool Group (NYSE:EPAC) is likely to report quarterly earnings at $0.12 ... 
Tags GIS VITL PXS
From Benzinga
FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
Biotech stocks reversed course in the week ended March 19 amid mixed news flow on data readouts and lackluster broader market ... 
Tags TELA IPOs Earnings
From Benzinga
Aptinyx to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 24, 2021
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company... 
From Business Wire News Releases
Aptinyx to Participate in Upcoming Investor Conferences
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company... 
From Business Wire News Releases
Aptinyx to Participate at 10th Annual SVB Leerink Global Healthcare Conference
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company... 
From Business Wire News Releases
Return On Capital Employed Overview: Aptinyx
Aptinyx (NASDAQ:APTX) reported Q3 sales of $257.00 thousand. Earnings fell to a loss of $11.42 million, resulting in a 9.66% decrease ... 
Tags News APTX BZI/ROCE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 29, 2021
Upgrades For Western Digital Corp (NASDAQ:WDC), Evercore ISI Group upgraded the previous rating of In-Line to ... 
Tags SSB TRU PHM
From Benzinga
Aptinyx Announces Publication of Review Article Highlighting Preclinical Data in Medicine in Drug Discovery Demonstrating the Potential of NYX-2925 to Treat Chronic, Centralized Pain Conditions
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the publication of a... 
From Business Wire News Releases
Aptinyx to Participate in H.C. Wainwright BioConnect 2021 Conference
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company... 
From Business Wire News Releases
Aptinyx Announces Recommencement of Phase 2 Study of NYX-2925 in Patients With Painful Diabetic Peripheral Neuropathy
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that in December it... 
From Business Wire News Releases
Aptinyx to Present at the 39th Annual J.P. Morgan Healthcare Conference
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company... 
From Business Wire News Releases
First Week of APTX August 2021 Options Trading
Investors in Aptinyx Inc (APTX) saw new options begin trading this week, for the August 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the... 
Tags Stocks
From Market News Video
Qualcomm’s new chipset for wireless earbuds promises improved noise cancellation, all-day battery life
There are now so many wireless earbuds, it’s hard to keep track, but one of the reasons why we’ve seen this explosion in new and existing manufacturers entering this business is the availability of... 
Tags Alexa aptx smartphones
From TechCrunch
Aptinyx Appoints Andy Kidd, M.D., President and Chief Operating Officer
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the appointment of... 
From Business Wire News Releases
Aptinyx Reports Third Quarter 2020 Financial Results and Recent Highlights
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today reported financial results for... 
From Business Wire News Releases
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FPRX Benzinga Penny Stocks
From Benzinga
Earnings Scheduled For November 12, 2020
Companies Reporting Before The Bell • Redhill Biopharma (NASDAQ:RDHL) is projected to report quarterly loss at $0.16 ... 
Tags INTZ TIG LMB
From Benzinga
Aptinyx to Participate in Upcoming Virtual Investor Conferences
EVANSTON, Ill., November 10, 2020 – Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders,... 
From Business Wire News Releases
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags Small Cap PRAX VIVO
From Benzinga
Aptinyx to Report Third Quarter Financial Results on Thursday, November 12, 2020
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback